Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)
Clinical Infectious Diseases · 27.06.2024 · 78 (7) · e83-e102
DOI: 10.1093/cid/ciaa478 ↗Kurz gefasst
Leitlinie in der Zeitschrift Clinical Infectious Diseases, online erschienen am 27.04.2020. Verfasst von Adarsh Bhimraj und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Cleveland Clinic, Cleveland, Ohio. Die Arbeit wurde bisher 438-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Infectious Diseases Society of America.
Abstract (Originalsprache)
Background
There are many pharmacologic therapies that are being used or considered for treatment of coronavirus disease 2019 (COVID-19). There is a need for frequently updated practice guidelines on their use, based on critical evaluation of rapidly emerging literature. The objective was to develop evidence-based rapid guidelines intended to support patients, clinicians, and other healthcare professionals in their decisions about treatment and management of patients with COVID-19.
Methods
The Infectious Diseases Society of America (IDSA) formed a multidisciplinary guideline panel of infectious disease clinicians, pharmacists, and methodologists with varied areas of expertise. Process followed a rapid recommendation checklist. The panel prioritized questions and outcomes. Then a systematic review of the peer-reviewed and gray literature was conducted. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach was used to assess the certainty of evidence and make recommendations.
Results
The IDSA guideline panel agreed on 7 treatment recommendations and provided narrative summaries of other treatments undergoing evaluations.
Conclusions
The panel expressed the overarching goal that patients be recruited into ongoing trials, which would provide much-needed evidence on the efficacy and safety of various therapies for COVID-19, given that we could not make a determination whether the benefits outweigh harms for most treatments.
Autor:innen und Institutionen
- Department of Infectious Diseases, Cleveland Clinic, Cleveland, Ohio.
- Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario.
- VA Northeast Ohio Healthcare System, Case Western Reserve University School of Medicine, Cleveland, Ohio.
- Department of Pathology and Laboratory Medicine, Vancouver General Hospital, Vancouver, British Columbia, Canada.
- Brigham and Women's Hospital, Boston, Massachusetts.
- Queen Mary Hospital, Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.
Förderung
- Infectious Diseases Society of America
Zitieren
APA
Bhimraj, A., Morgan, R. L., Shumaker, A. H., Lavergne, V., Baden, L., Cheng, V. C., Edwards, K. M., Gandhi, R., Muller, W. J., O'Horo, J. C., Shoham, S., Murad, M. H., Mustafa, R. A., Sultan, S., & Falck-Ytter, Y. (2024). Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020). Clinical Infectious Diseases, 78(7), e83-e102. https://doi.org/10.1093/cid/ciaa478
Vancouver
Bhimraj A, Morgan RL, Shumaker AH, Lavergne V, Baden L, Cheng VC, et al. Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020). Clinical Infectious Diseases. 2024;78(7):e83-e102. doi:10.1093/cid/ciaa478
BibTeX
@article{Bhimraj2024,
author = {Bhimraj, Adarsh and Morgan, Rebecca L and Shumaker, Amy Hirsch and Lavergne, Valery and Baden, Lindsey and Cheng, Vincent Chi-Chung and Edwards, Kathryn M and Gandhi, Rajesh and Muller, William J and O'Horo, John C and Shoham, Shmuel and Murad, M Hassan and Mustafa, Reem A and Sultan, Shahnaz and Falck-Ytter, Yngve},
title = {Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)},
journal = {Clinical Infectious Diseases},
year = {2024},
volume = {78},
number = {7},
pages = {e83--e102},
doi = {10.1093/cid/ciaa478}
}
EUVIMED